Our study further delineates a functional link where KDM5B downregulates PLK2 expression by reducing the H3K4me3 levels at the promoter, thereby activating the PI3K/AKT/mTOR pathway to promote tumor progression in EBV-associated epithelial tumors. Here, KDM5B is linked to neoplasm.